French health authority advises against Moderna Covid-19 vaccine for under 30s
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
SATURDAY, MAY 21, 2022
SATURDAY, MAY 21, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
French health authority advises against Moderna Covid-19 vaccine for under 30s

Coronavirus chronicle

Reuters
09 November, 2021, 04:55 pm
Last modified: 09 November, 2021, 04:55 pm

Related News

  • On 'burkini' row, it is French government vs city of Grenoble
  • Macron picks Elisabeth Borne as new prime minister
  • Macron suggests new European entity
  • France's Macron sworn in for second term as president
  • Armed robbers strike Chanel jewellery store in Paris and flee on motorbikes

French health authority advises against Moderna Covid-19 vaccine for under 30s

The Haute Autorite de Sante (HAS), which does not have legal power to ban or licence drugs but acts as an advisor to the French health sector, cited "very rare" risks linked to Myocarditis, a heart disease, that had shown up in recent data on the Moderna vaccine and in a French study published on Monday

Reuters
09 November, 2021, 04:55 pm
Last modified: 09 November, 2021, 04:55 pm
A healthcare worker holds a vial of the Moderna Covid-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (Covid-19) pandemic in Manhattan in New York City, New York, US, January 29, 2021. Photo :Reuters
A healthcare worker holds a vial of the Moderna Covid-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (Covid-19) pandemic in Manhattan in New York City, New York, US, January 29, 2021. Photo :Reuters

France's public health authority has recommended people under 30 be given Pfizer's Comirnaty Covid-19 vaccine when available instead of Moderna Inc's Spikevax jab, which carried comparatively higher risks of heart-related problems.

The Haute Autorite de Sante (HAS), which does not have legal power to ban or licence drugs but acts as an advisor to the French health sector, cited "very rare" risks linked to Myocarditis, a heart disease, that had shown up in recent data on the Moderna vaccine and in a French study published on Monday.

"Within the population aged under 30, this risk appears to be around five times lesser with Pfizer's Comirnaty jab compared to Moderna's Spikevax jab," HAS said in its opinion published on Monday.

HAS said that its recommendation, which would apply regardless of the vaccine's use as a first, second or third "booster" dose, would be valid until more scientific findings on the matter are known.

For persons aged over 30, however, the authority explicitly recommended the use of the Moderna vaccine, saying its effectiveness was slightly superior.

The European Union's drug regulator last month approved Moderna's booster vaccine, saying in its review that the jab may be given to people aged 18 years and above, at least six months after the second dose.

Moderna Covid-19 Vaccine / France

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Infographic: TBS
    Tough conditions get in way of Indian wheat import
  • Zahid Hussain/TBS Sketch
    Our problematic macroeconomic duo
  • US growth seen outpacing China’s for first time since 1976
    US growth seen outpacing China’s for first time since 1976

MOST VIEWED

  • A worker disinfects a vehicle carrying medical oxygen, in Pyongyang. Photo: Collected
    North Korea using traditional medicine to fight Covid
  • Ryu Yong Chol, an official at North Korea's state emergency epidemic prevention headquarters, speaks during a daily coronavirus program on state-run television KRT, in this still image obtained from KRT footage released on May 20, 2022. REUTERS TV/KRT via REUTERS
    North Korea's Dr Fauci? Health official emerges as face of Covid campaign
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Shanghai detects new infections after five days of 'zero Covid'
  • Volunteers carry out temperature screening during an anti-virus campaign in Pyongyang, North Korea in this image released by North Korea's Korean Central News Agency (KCNA) on March 4, 2020. KCNA via REUTERS/File Photo
    North Korea hails 'good results' on Covid as fever cases pass 2 million
  • Medical staff members check the temperature of people as they enter at Capital Airport, following an outbreak of Covid-19, in Beijing, China, 5 November, 2020. Photo: Reuters
    China relaxes some Covid test rules for US, other travellers
  • Representational image.
    China Junshi's potential Covid drug shows promise in small trial

Related News

  • On 'burkini' row, it is French government vs city of Grenoble
  • Macron picks Elisabeth Borne as new prime minister
  • Macron suggests new European entity
  • France's Macron sworn in for second term as president
  • Armed robbers strike Chanel jewellery store in Paris and flee on motorbikes

Features

Mohammad (Mejbah) Mejbahuddin, Former Senior Secretary, Economic Relations Division (ERD), Ministry of Finance, Government of Bangladesh. TBS Sketch

‘No project is being delayed too long at the moment’

13h | Panorama
Dr Shamsul Hoque, Professor, Civil Engineering, BUET. TBS Sketch

‘Planning commission only in the name, there are no planners’ 

13h | Panorama
Masrur Reaz. TBS Sketch

‘To ensure accountability, contract financing should be based on ‘performance based payments’

13h | Panorama
Professor Mustafizur Rahman. Illustration: TBS

Project delays and escalating costs are driven by frequent revisions and lack of good governance

17h | Panorama

More Videos from TBS

Ways to retain body fragrance

Ways to retain body fragrance

15h | Videos
Gazipur restaurant that serves 150 food items

Gazipur restaurant that serves 150 food items

18h | Videos
How to prepare for a job

How to prepare for a job

19h | Videos
Putin's strategies to face Nato

Putin's strategies to face Nato

1d | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

3
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

4
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

5
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

6
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab